Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Non-Board Appointments

9 May 2005 07:01

Premier Research Group09 May 2005 For Immediate Release 9 May 2005 Premier Research appoints Anthony Orlando and Bruce C Stouch to New Senior Management Positions Premier Research Group plc (AIM: PRG) ("Premier Research", "Company" or "Group"), the international pharmaceutical services group today announces theappointment of -- Anthony Orlando, Ph.D and Bruce C Stouch Ph.D to seniormanagement positions in Premier Research. Dr Anthony Orlando, Ph.D has joined the US Operations of Premier Research Groupplc in the new position of Executive Director, Data Operations. Dr. Orlandobrings an exceptional background in Biostatistics and Data Management over thepast thirty years including key roles in pharmaceutical companies, the NationalCenter for Toxicological Research/FDA and at major contract researchorganizations. He most recently joined the company from his position as VicePresident, Biostatistics at SFBC New Drug Services. Dr. Orlando holds a Ph.D. inBiometry from Yale University, has co-authored many papers in his area ofexpertise and has supported several drug NDAs for a variety of indications. Hewill be responsible for US data management, programming and biostatistics forPremier Research. In addition to Dr. Orlando's position, Premier Research also is pleased toannounce that Bruce C. Stouch, Ph.D. has taken the international position ofChief Scientific Officer for the company. In Dr. Stouch's new role, he will leadthe company's efforts supporting expert FDA/statistical clinical design andanalysis capabilities. He will also establish and expand the company's newinitiative into Bayesian monitoring and analysis methods. Dr. Stouch has over15 years of biostatistics experience in pharmaceuticals. For 12 years, Dr. Stouch held position of Director of Biostatistics andScientific Data Management at Johnson & Johnson in Exton, PA, where he wasresponsible for strategic development and implementation of pharmacoeconomicmodels of emerging technologies in several therapeutic areas. Dr. Stouch hasbeen involved in over two dozen publications and acknowledgements. He holds anacademic appointment at the Philadelphia College of Medicine as Director,Biostatistics and Clinical Epidemiology. Dr. Stouch received his Ph.D. inBiostatistics and Epidemiology from Jefferson Medical College in 1997 through aprogram sponsored by Johnson & Johnson, and trained in post-graduate studiesfrom Temple University, Jefferson Medical College, and Harvard School of PublicHealth. Dr Simon Yaxley, CEO of Premier Research Group plc, commented: "We are proud andpleased to announce the significant strengthening of our data management andstatistics capabilities in the US Operations, we also believe that Tony andBruce place our company at the forefront of trial design, monitoring andanalysis methods worldwide." About Premier Research Premier Research Group plc is a contract research organisation focused on thedesign, management and reporting of all phases of clinical trials on behalf ofpharmaceutical and biotechnology companies. The Company specialises in oncology,central nervous system, paediatrics and anti-infectives. For Further information, please contact: Premier Research Group Plc Tel: 01344 458 311Dr Simon Yaxley, Chief Executive Buchanan Communications Tel: 020 7466 5000Lisa Baderoon/Diane Stewart/Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Dec 20157:00 amPRNCorporate Update
14th Dec 20155:00 pmPRNUpdate on Mothae
24th Nov 20158:50 amRNSResignation of Nominated Adviser and Broker
20th Nov 20151:22 pmRNSUpdate Regarding Suspension
16th Nov 20157:47 amRNSTemporary Suspension
16th Nov 20157:45 amRNSSuspension - Paragon Diamonds Limited
7th Oct 20157:00 amPRNCorporate and Mothae acquisition update
2nd Oct 20155:10 pmPRNHoldings in Company
2nd Oct 20157:00 amPRN$15 million Debt and Revenue Sharing Facility
30th Sep 20157:00 amPRNInterim Results
15th Sep 201511:30 amPRNPositive Technical Study for Mothae Kimberlite Project
7th Aug 20157:00 amPRNGovernment approval for acquisition of Mothae
4th Aug 201512:40 pmPRNResult of AGM
15th Jul 20157:02 amPRNHolding(s) in Company
15th Jul 20157:00 amPRNHolding(s) in Company
14th Jul 20157:00 amPRNMothae Acquisition Update
7th Jul 201511:56 amPRNHolding(s) in Company
29th Jun 20151:34 pmPRNAnnual Report and Notice of AGM
26th Jun 20157:00 amPRNFinal Results
18th Jun 20157:00 amPRNGBP500,000 debt financing & Share buyback programme
5th May 20157:00 amPRNMOU to acquire Mothae Kimberlite Project in Lesotho
25th Mar 20151:50 pmPRNHolding(s) in Company
25th Mar 20151:45 pmPRNHolding(s) in Company
13th Mar 20157:00 amPRNUpdate on Lemphane Diamond Project and Placing
3rd Mar 20157:01 amPRNHolding(s) in Company
3rd Mar 20157:00 amPRNHolding(s) in Company
28th Jan 20157:00 amPRNBinding MoU - US$12m equity and debt finance package
9th Jan 201512:52 pmPRNHolding(s) in Company
12th Dec 20147:01 amPRNShare Buy Back and Total Voting Rights
12th Dec 20147:00 amPRNHolding(s) in Company
9th Dec 201411:43 amPRNResult of General Meeting
8th Dec 20147:00 amPRNHoldings in Company
5th Dec 20147:00 amPRNIssue of Equity
4th Dec 201412:56 pmPRNOperations Update
25th Nov 20147:00 amPRNUpdate on Processing Plant - Lemphane Kimberlite Lesotho
20th Nov 201411:30 amPRNExercise of option by Titanium
17th Nov 20147:00 amPRNSale of large high value diamonds - Lemphane Lesotho
14th Nov 20147:00 amPRNPosting of Circular and Notice of General Meeting
13th Nov 20147:00 amPRNLesotho Subsidiary Board Changes
11th Nov 20147:00 amPRNDirectorate Change
11th Nov 20147:00 amPRNAppointment of Adviser
11th Nov 20147:00 amPRNAcquisition of Lanstead Holding in Company
1st Oct 201410:52 amPRNTotal Voting Rights
26th Sep 20147:00 amPRNIssue of Equity
25th Sep 201410:53 amPRNHoldings in Company
15th Sep 20147:01 amPRNInterim Results
15th Sep 20147:00 amPRNAppointment of Broker
27th Aug 20147:00 amRNSUpdate re: Paragon Diamonds Ltd
27th Aug 20147:00 amPRNBoard Changes & Transfer of Convertible Loan Agreement
15th Jul 20144:21 pmPRNResponse to Press Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.